Capricor Therapeutics (CAPR) Change in Account Payables (2010 - 2014)

Capricor Therapeutics (CAPR) recorded quarterly Change in Account Payables of -$61582.0 in Q3 2014, down 730.7% quarter-over-quarter from $9764.0 in Q2 2014, and down 49.5% on a YoY basis from -$121944.3 in Q3 2013.

Capricor Therapeutics (CAPR) Change in Account Payables (2010 - 2014) Analysis & Trends

Capricor Therapeutics' Change in Account Payables history runs 5 years deep, the most recent figure standing at -$61582.0 for Q3 2014.

  • In Q3 2014, Change in Account Payables fell 49.5% year-over-year to -$61582.0; the TTM figure through Sep 2014 stood at $109224.0 (down 37.31% YoY), while the FY2013 annual figure was $97512.0, changed N/A from the prior year.
  • Change in Account Payables was -$61582.0 for Q3 2014 at Capricor Therapeutics, down from $9764.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $437525.0 in Q3 2010 to a low of -$259173.0 in Q4 2010.
  • Historically, Change in Account Payables has averaged $19968.6 across 5 years, with a median of $9764.0 in 2014.
  • Biggest YoY gain for Change in Account Payables was 442.56% in 2012; the steepest drop was 175.56% in 2012.
  • A 5-year view of Change in Account Payables shows it stood at -$259173.0 in 2010, then jumped by 74.34% to -$66496.0 in 2011, then jumped by 442.56% to $227787.0 in 2012, then plunged by 33.68% to $151079.0 in 2013, then plunged by 140.76% to -$61582.0 in 2014.
  • The last three Change in Account Payables figures came in at -$61582.0 (Q3 2014), $9764.0 (Q2 2014), and $9963.0 (Q1 2014), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -3.26 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 35.60 Mn
9 Abivax 94.26 Bn 94.26 Bn - -9.42 Mn
10 Capricor Therapeutics 1.53 Bn 1.26 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2014 -61,582.00
Sep 30, 2014 -61,582.00
Jun 30, 2014 9,764.00
Jun 30, 2014 9,764.00
Mar 31, 2014 9,963.00
Mar 31, 2014 9,963.00
Dec 31, 2013 151,079.00
Dec 31, 2013 151,079.00
Sep 30, 2013 -41,192.00
Sep 30, 2013 -41,192.00
Jun 30, 2013 -22,338.00
Jun 30, 2013 -22,338.00
Mar 31, 2013 9,963.00
Mar 31, 2013 9,963.00
Dec 31, 2012 227,787.00
Dec 31, 2012 227,787.00
Sep 30, 2012 88,331.00
Sep 30, 2012 88,331.00
Jun 30, 2012 -205,435.00
Jun 30, 2012 -205,435.00